New York State Common Retirement Fund
CADL icon

New York State Common Retirement Fund’s Candel Therapeutics CADL Stock Holding History

New York State Common Retirement Fund’s Portfolio CADL Stock Details CADL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$147K Buy
14,300
+12,600
+741% +$95.2K ﹤0.01% 2497
2026
Q1 		$8.33K Hold
1,700
– – ﹤0.01% 3096
2025
Q4 		$9.61K Hold
1,700
– – ﹤0.01% 3143
2025
Q3 		$8.67K Hold
1,700
– – ﹤0.01% 3163
2025
Q2 		$8.6K Hold
1,700
– – ﹤0.01% 3166
2025
Q1 		$9.61K Hold
1,700
– – ﹤0.01% 3082
2024
Q4 		$14.8K Hold
1,700
– – ﹤0.01% 3086
2024
Q3 		$11.8K Sell
1,700
-15,300
-90% -$95K ﹤0.01% 3096
2024
Q2 		$105K Buy
+17,000
New +$128K ﹤0.01% 2738

Other funds holding CADL

HFF
Halter Ferguson Financial Carmel, Indiana $617M AUM 69.99% 1-Year Est. Return
TWM
Tanager Wealth Management Goring On Thames, United Kingdom $1.15B AUM 19.91% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
TGIA
Torrey Growth & Income Advisors Del Mar, California $294M AUM 37.95% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

New York State Common Retirement Fund's CADL Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Candel Therapeutics (CADL) stake by 741% in Q2 2026, buying an estimated $95.2K and bringing the position to 14,300 shares worth $147K. The position accounts for ﹤0.01% of the portfolio, ranked #2497.

New York State Common Retirement Fund first reported a position in CADL in Q2 2024 and has held it in 9 quarters since. 29 funds tracked by Wall St. Rank hold CADL as of Q2 2026.

  • New York State Common Retirement Fund held 14,300 shares of Candel Therapeutics worth $147K as of Q2 2026.
  • New York State Common Retirement Fund bought 12,600 Candel Therapeutics shares in Q2 2026, an estimated $95.2K.
  • Candel Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2497 holding.
  • New York State Common Retirement Fund first reported a position in Candel Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • 29 funds tracked by Wall St. Rank held Candel Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.